Article Details
Retrieved on: 2022-11-28 19:00:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca (AZ) and C4X Discovery (C4XD) have signed an exclusive worldwide licensing agreement worth up to $403m to develop an oral therapy for ...
Article found on: www.pmlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here